Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Nov-24 7:19 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 12-Nov-24 | Sale (Planned) | 11,447 | $7.64 | $87,457.40 | (< 1%) 7.08M to 7.07M | |
| 04-Oct-24 6:30 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Oct-24 | Grant | 2,026 | -- | -- | < 1% 7.1M to 7.1M | |
| 19-Sep-24 5:48 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Sep-24 | Sale (Planned) | 11,447 | $6.84 | $78,333.00 | (< 1%) 7.12M to 7.11M | |
| 05-Sep-24 5:25 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Sep-24 | Sale (Planned) | 11,447 | $6.27 | $71,717.70 | (< 1%) 7.13M to 7.12M | |
| 22-Aug-24 6:48 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Aug-24 | Sale (Planned) | 11,447 | $7.12 | $81,532.40 | (< 1%) 7.14M to 7.13M | |
| 08-Aug-24 5:23 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Aug-24 | Sale (Planned) | 11,447 | $6.82 | $78,083.40 | (< 1%) 7.16M to 7.14M | |
| 25-Jul-24 6:15 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 23-Jul-24 | Sale (Planned) | 11,447 | $8.48 | $97,040.80 | (< 1%) 7.17M to 7.16M | |
| 11-Jul-24 4:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Jul-24 | Sale (Planned) | 11,447 | $7.32 | $83,734.80 | (< 1%) 7.18M to 7.17M | |
| 27-Jun-24 7:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jun-24 | Sale (Planned) | 11,447 | $9.51 | $108,806.00 | (< 1%) 7.19M to 7.18M | |
| 13-Jun-24 5:36 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 11-Jun-24 | Sale (Planned) | 11,447 | $8.45 | $96,762.60 | (< 1%) 7.2M to 7.19M | |
| 05-Jun-24 6:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jun-24 | Grant | 13,097 | -- | -- | < 1% 7.19M to 7.2M | |
| 30-May-24 6:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-May-24 | Sale (Planned) | 11,447 | $9.17 | $104,943.00 | (< 1%) 7.2M to 7.19M | |
| 16-May-24 4:35 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-May-24 | Sale (Planned) | 20,054 | $10.12 | $202,934.00 | (< 1%) 7.22M to 7.2M | |
| 02-May-24 5:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 30-Apr-24 | Sale (Planned) | 11,447 | $7.95 | $90,963.60 | (< 1%) 7.23M to 7.22M | |
| 18-Apr-24 5:12 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Apr-24 | Sale (Planned) | 11,447 | $7.66 | $87,725.20 | (< 1%) 7.24M to 7.23M | |
| 03-Apr-24 5:42 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Apr-24 | Sale (Planned) | 11,447 | $8.82 | $100,942.00 | (< 1%) 7.25M to 7.24M | |
| 21-Mar-24 5:38 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 19-Mar-24 | Sale (Planned) | 20,054 | $10.79 | $216,423.00 | (< 1%) 7.27M to 7.25M | |
| 07-Mar-24 6:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 05-Mar-24 | Sale (Planned) | 20,054 | $12.06 | $241,805.00 | (< 1%) 7.29M to 7.27M | |
| 21-Feb-24 5:37 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Feb-24 | Sale (Planned) | 20,054 | $12.32 | $247,125.00 | (< 1%) 7.31M to 7.29M | |
| 08-Feb-24 6:54 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 06-Feb-24 | Sale (Planned) | 11,447 | $9.30 | $106,489.00 | (< 1%) 7.32M to 7.31M | |
| 25-Jan-24 6:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 23-Jan-24 | Sale (Planned) | 20,054 | $10.58 | $212,083.00 | (< 1%) 7.34M to 7.32M | |
| 11-Jan-24 6:50 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Jan-24 | Market Sale (Planned) | 20,054 | $13.62 | $273,202.00 | (< 1%) 7.36M to 7.34M | (13%) |
| 28-Dec-23 5:48 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 26-Dec-23 | Sale (Planned) | 20,054 | $10.63 | $213,144.00 | (< 1%) 7.38M to 7.36M | |
| 14-Dec-23 6:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 12-Dec-23 | Sale (Planned) | 11,447 | $7.40 | $84,692.90 | (< 1%) 7.4M to 7.38M | |
| 30-Nov-23 5:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 28-Nov-23 | Sale (Planned) | 11,447 | $6.72 | $76,918.10 | (< 1%) 7.41M to 7.4M | |
| 16-Nov-23 6:55 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Nov-23 | Sale (Planned) | 8,885 | $6.32 | $56,150.50 | (< 1%) 7.42M to 7.41M | |
| 02-Nov-23 7:02 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 31-Oct-23 | Sale (Planned) | 8,885 | $5.27 | $46,863.90 | (< 1%) 7.43M to 7.42M | |
| 19-Oct-23 5:34 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Oct-23 | Sale (Planned) | 8,885 | $6.58 | $58,482.80 | (< 1%) 7.43M to 7.43M | |
| 05-Oct-23 6:25 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Oct-23 | Sale (Planned) | 8,885 | $7.29 | $64,777.90 | (< 1%) 7.44M to 7.43M | |
| 21-Sep-23 6:35 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 19-Sep-23 | Sale (Planned) | 8,885 | $8.36 | $74,277.70 | (< 1%) 7.45M to 7.44M | |
| 07-Sep-23 7:02 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 05-Sep-23 | Sale (Planned) | 8,885 | $8.79 | $78,136.50 | (< 1%) 7.46M to 7.45M | |
| 24-Aug-23 5:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 22-Aug-23 | Sale (Planned) | 8,885 | $8.91 | $79,181.30 | (< 1%) 7.47M to 7.46M | |
| 10-Aug-23 5:33 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 08-Aug-23 | Sale (Planned) | 17,770 | $11.16 | $198,283.00 | (< 1%) 7.49M to 7.47M | |
| 27-Jul-23 6:30 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 25-Jul-23 | Sale (Planned) | 18,719 | $14.61 | $273,464.00 | (< 1%) 7.51M to 7.49M | |
| 13-Jul-23 4:54 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 11-Jul-23 | Sale (Planned) | 8,885 | $6.89 | $61,193.70 | (< 1%) 7.53M to 7.52M | |
| 27-Jul-23 6:30 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 29-Jun-23 | Gift | 14,000 | -- | -- | (< 1%) 7.52M to 7.51M | |
| 29-Jun-23 5:57 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 27-Jun-23 | Sale (Planned) | 8,885 | $7.39 | $65,638.80 | (< 1%) 7.54M to 7.53M | |
| 21-Jun-23 5:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jun-23 | Grant | 12,612 | -- | -- | < 1% 7.53M to 7.54M | |
| 15-Jun-23 7:30 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 13-Jun-23 | Sale (Planned) | 15,485 | $9.98 | $154,506.00 | (< 1%) 7.54M to 7.53M | |
| 01-Jun-23 5:41 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 30-May-23 | Sale (Planned) | 8,885 | $8.79 | $78,133.80 | (< 1%) 7.55M to 7.54M | |
| 17-May-23 6:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-May-23 | Sale (Planned) | 8,885 | $5.09 | $45,240.60 | (< 1%) 7.56M to 7.55M | |
| 20-Apr-23 5:37 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 18-Apr-23 | Sale (Planned) | 8,885 | $5.93 | $52,729.80 | (< 1%) 7.57M to 7.56M | |
| 06-Apr-23 5:38 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 04-Apr-23 | Sale (Planned) | 8,885 | $6.53 | $57,991.50 | (< 1%) 7.58M to 7.57M | |
| 23-Mar-23 5:07 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 21-Mar-23 | Sale (Planned) | 8,885 | $7.40 | $65,743.70 | (< 1%) 7.59M to 7.58M | |
| 09-Mar-23 5:36 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Mar-23 | Sale (Planned) | 8,885 | $8.33 | $73,989.00 | (< 1%) 7.59M to 7.59M | |
| 23-Feb-23 5:48 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 21-Feb-23 | Sale (Planned) | 8,885 | $7.73 | $68,707.70 | (< 1%) 7.6M to 7.59M | |
| 09-Feb-23 4:53 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Feb-23 | Sale (Planned) | 8,885 | $8.81 | $78,262.60 | (< 1%) 7.61M to 7.6M | |
| 26-Jan-23 6:04 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 24-Jan-23 | Sale (Planned) | 8,885 | $8.71 | $77,367.90 | (< 1%) 7.62M to 7.61M | |
| 12-Jan-23 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 10-Jan-23 | Sale (Planned) | 8,885 | $7.69 | $68,283.00 | (< 1%) 7.63M to 7.62M | |
| 05-Jan-23 6:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-23 | Grant | 1,325 | -- | -- | < 1% 7.63M to 7.63M |